Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of June 8th – 14th, 2020.... read more →
After Getting Off to a Good Start as a Psychotherapeutic Tool By the Middle of the Last Century, It Looked Like Psychedelics Would Become Part of the Medical Mainstream Then... read more →
It's Been an Incredible Year to Date for the Psychedelics Leader Champignon Brands, Here's a List of the Company's Top Accomplishments and Milestones Over the Last Quarter Also, the Company... read more →
The Champignon Brands Offering Included the Full Exercise of Options Granted to the Deal's Underwriters Proceeds of the Financing Will Allow the Psychedelics Leader to Accelerate its North American Clinical... read more →
With the New Dalriada Partnership, Champignon Expects to Develop a Robust Pipeline of Preclinical and Clinical Assets with Strong IP Protection Dalriada’s Medicinal Chemistry Expertise Combined with Champignon’s Innovative Formulation... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of June 1st – 7th, 2020.... read more →
Psychedelics Companies That Own Clinics May Hold the Answer to One of the Top Investor Questions: "How Will Individual Firms Generate Meaningful Revenue?" As We Know, the Business of Biotech... read more →
